Pallas for a four-week renewal quote
Use the initial and renewal prices in our Pallas review to calculate both debits. Ask what amount the clinician’s prescription would trigger for the selected plan.
Head-to-head · WeighScore
By GLP-1 ScorecardUpdated
I’d use Pallas’s published four-week renewal prices as a starting point for a budget. Ask PauseRX how much supply its quoted payment covers and when you would be charged again. Check the order cutoff before relying on either provider’s cancellation options.
Use the initial and renewal prices in our Pallas review to calculate both debits. Ask what amount the clinician’s prescription would trigger for the selected plan.
The policy in our PauseRX review treats charged orders as final after carrier handoff. Confirm the amount due, the next billing date and the cutoff for the selected order.
Align the supply periods before comparing the cost of the first and subsequent fills.
Score comparison
Pallas Health has the higher recorded score — 69.3/100 to 68.5/100, but only just.
Pallas Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Pallas advertises four-week renewal or an annual option for compounded injections. Ask for the full amount due and confirm when a prescribed order becomes final. PauseRX is close behind and may still be the better fit — see the factor split below.
Before comparing the headline prices, the Pallas Health review and the PauseRX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Pallas Health vs Regenics and PauseRX vs Regenics compare each of them with another graded program, and the list of alternatives to Pallas Health ranks the programs closest to Pallas Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the MyDrHank review covers one graded close to these two, at 68.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
Swipe or scroll to compare both providers.
| Metric | Pallas Health | PauseRX |
|---|---|---|
| WeighScore | 69.3/100 | 68.5/100 |
| Grade | C | C |
| Site position | #142 | #162 |
| Semaglutide | $139 first period, then $199 every four weeks (compounded; confirm selected quote) | Compounded GLP-1 from $199; confirm selected supply and charge |
| Tirzepatide | $179 first period, then $299 every four weeks (compounded; confirm selected quote) | Compounded GLP-1/GIP from $249; confirm selected supply and charge |
| Coverage | Confirm treatment and visit requirements for your state | Confirm availability for the selected product and state |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Yes |
Strengths
What to consider
Strengths
What to consider
Featured provider
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.